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1.1 Background and Motivation: CHAPTER II Overview
Because traumatic damage to the central nervous system (CNS) (in particular,
brain and spinal cord) has no clinical cure, various regenerative and reparative strate-
gies are under scientific investigation. The current literature in CNS regeneration
is focused largely on the following components: biomaterials, neurotrophic factors,
and cells. Though there is a consensus that the ultimate treatment will consist of
a combination of these components, the effects of each individual component should
be understood to enable practical testing of the most promising combinations.
In the category of biomaterials, recent research has investigated the ability of
the materials to deliver the other two components, neurotrophic factors and cells,
to central nervous system defects (Schwab et al., 2006; Schmidt and Leach, 2003).
Architectures and topographies of these biomaterials have been of interest mostly
on the cellular scale, or micro-scale, for influencing cell behavior based on contact
guidance (Curtis and Wilkinson, 1997).
The macro-scale architectures are not as diversely investigated as the micro-scale
topography. Single and multi-channeled guidance tubes are the most commonly
used macro-architectures for spinal cord injury (Nomura et al., 2006). Treatments
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for traumatic brain injury have only used hydrogels and sponges with no macro-
architecture at all (Schouten et al., 2004; Hou et al., 2005; Tian et al., 2005a). The
focus of each study has been the neurotrophic factors or cells used in conjunction
with the biomaterial, or preliminary study of a single biomaterial construct for later
pairing with neurotrophic factors or cells. There have been no rigorous comparative
studies of macro-architectures of biomaterials in brain or spinal cord defects.
There is some evidence that macro-architecture could influence nervous tissue
regeneration. In other tissues such as bone and cartilage, interconnected pores and
open macro-architectural features improve tissue ingrowth (Li et al., 2007; Malda et
al., 2005; Otsuki et al., 2006), aspects which have not been studied in brain tissue but
may be important. Also in a spinal cord transection model, a 4-channeled guidance
tube improves neuronal regeneration and functional recovery over a single channeled
tube, presumably due to increased surface area (Tsai et al., 2006).
The influence of macro-architecture is suggested in these studies, but the extent of
influence is unknown. If the architecture of a scaffold on its own is able to improve
the regeneration potential in the CNS, its use would enhance the effects of other
combination treatments like neurotrophic factors or implanted cells. Use of effective
architectures could also potentially decrease any dosing requirements for expensive
or limited treatments such as recombinant proteins or autologous cells. It is thus
hypothesized that creating a more diverse set of macro-architectures based on known
anatomical characteristics of the tissue would improve the regenerative capacity of
the CNS.
3
1.2 Identifying PCL as suitable material for studying macro-architecture
in CNS: CHAPTER III Overview
Rationale: The brain and spinal cord are very different in structure and organi-
zation though they contain similar cell types. Therefore, reactions to scaffolds and
appropriate architectures would likely be different. Before testing the main hypoth-
esis in the two model systems, brain and spinal cord, a model material was chosen.
Two degradable materials were chosen to fit the following criteria: 1) strength enough
to maintain a macro-architecture yet elastic enough to be used in soft tissue, 2) the
ability to accommodate controlled drug release or surface modification in future ap-
plications 3) non-immunogenic and 4) do not completely degrade within a few weeks
in vivo. A rat cerebral cortex defect model similar to other published research was
chosen for ease of study and comparison (Tian et al., 2005a). The defect is relatively
superficial in the brain and does not cause any functional loss, thus surgery remains
simple and husbandry duties remain at a minimum. Cortical loss is also typical in
traumatic brain injury.
Summary: Poly(e-caprolacton) (PCL) and poly(lactic-co-glycolic acid) (PLGA)
were chosen to be examined in brain for biocompatibility as porous scaffolds. Both
were found to suppress defect growth, a result of secondary cell death, over the control
containing no material. Additionally, the PCL implant contained fewer MHC-II pos-
itive activated macrophages, but activated more CD11b positive resident microglia
at an earlier stage than PLGA, an indication that the cellular response was less in-
flammatory and more neuroprotective in PCL than PLGA. The remaining studies
thus were performed using salt-leached PCL as the base material.
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1.3 Designing and fabricating different architectures for CNS regenera-
tion in rat cortex model: CHAPTER IV Overview
Rationale: Macro-architectures have not been evaluated in scaffolds for brain
tissue regeneration. In the cerebral cortex, neurons are organized into six generally
transverse layers, parallel to the surface of the cortex. Their axons project vertically,
perpendicular to the surface, in columns connecting the cortex with deeper regions of
the brain. Information is therefore relayed between neurons in this vertical columnar
organization in groups spanning 300-600 µ wide. Macro-architectures were therefore
selected for study that incorporated these organizational directions and layers into
the guidance channels. The same cortical defect model was used here as in the first
polymer comparison study.
Summary: To test the hypothesis in the brain, interconnecting and isolated
channels and microgrooves were incorporated into a porous cylindrical scaffold with
the following combinations and implanted into a rat cerebral cortex defect extend-
ing inward 3 mm from the surface: 1) no channels or microgrooves, 2) 5 channels
and microgrooves along all walls oriented vertically in the brain, and 3) 5 channels
oriented vertically in the brain interconnected by orthogonally intersecting channels
parallel to the brain surface at 3 evenly distributed heights along the cylinder and
transverse microgrooves parallel to the brain surface.
The results demonstrated that, 8 weeks post-implantation, interconnected chan-
nels increased inward migration of glial cells (GFAP astrocytic marker), as well as or-
ganization of neuronal (Tuj-1 axonal marker) and progenitor (nestin filament marker)
cell types from the lateral parenchyma over porous scaffolds with non-interconnecting
channels and porous scaffolds with no channels at all. There was very little migration
of host cells from the center of the brain toward the surface. The results also showed
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that microgrooves increased organization and axonal projection along their direction
of orientation in vivo. Also larger pore sizes (100-250 µm versus < 50 µm ) increased
total cellular ingrowth. Thus, in the rat cerebral cortex, regeneration into a porous
scaffold can be enhanced with interconnecting channels and microgrooves oriented
in the direction of desired migration.
1.4 Designing and fabricating different architectures for spinal cord and
testing in a rat spinal cord transection model: CHAPTER V Overview
Rationale: Scaffold architectures in recent literature fall into three categories:
porous cylinder, single or multi-channeled tubes, and microfilament bundles. Though
their overall shape is influenced by the cylindrical shape of the spinal cord, their
architectures are not directly influenced by the locations of the white matter (cir-
cumferential) and gray matter (central). In addition, they all fill the defect cavity
to its lateral perimeters. Therefore designs were created to determine the benefit
of medial physical support for white matter tracts and the necessity of complete
circumferential presence.
Summary: To test the hypothesis in the spinal cord, porous scaffolds were made
in a variety of architectures: cylinder, tube, 5-channel, and two novel open-path
designs. These new designs were influenced by 1) the circumferential location of
white matter tracts, 2) the central core location of gray matter, 3) the cylindrical
bony enclosure provided by the spinal canal, and 4) the central canal, the conduit for
cerebrospinal fluid (CSF). There are rounded top and bottom shells attached with
fins to a central cylindrical core with a small channel through the middle (Figure
5.1). The core is designed to support the white matter tracts from the inside to
prevent the typical cavitation that occurs when the gray matter degenerates. The
core would also provide a medium for cell seeding to support gray matter regeneration
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in the future. A small channel through the center aims to reduce impedance of CSF
flow. The top and bottom shells are designed to provide structural support to the
central core, holding the core up in the middle, while also keeping scar and muscle
tissue above the defect from entering and inhibiting regeneration of the white matter.
The shells also provide added surfaces for white matter growth. The second novel
design is a control for the central core in that there are two shells but only one fin
connecting the shells and no central core. Thus it is a tube with discontinuous walls.
The discontinuous outer shells make the scaffold slightly narrower than the cylinder,
tube, and channel designs, facilitating their implantation without requiring excessive
removal of the spinal processes.
Implantation into a complete spinal cord transection at T8 resulted in fibrous
tissue encapsulation of the cylinder. Oriented fibrous tissue growth through both
the channels and the tube with no connecting neural tissue was observed through
GFAP and Tuj-1 immunohistochemistry. A high degree of secondary damage in
the cylinder, tube, and channel designs was observed from the doubling of the defect
length from the original size. The open-path designs were able to maintain the defect
length in the gray matter and also support robust nerve fiber growth around the outer
shells, bridging the defect site. Additionally the open-path design with a central core
cylinder was able to support axonal growth straddling the shells and within the core.
The improved integration of neural tissue and suppression of secondary damage in
the gray matter demonstrated that not only does scaffold architecture have an effect
on spinal cord regeneration, but a complete entubulation of the site and enclosure
of the defect site by guidance channels is not necessary to provide an environment
conducive to regeneration.
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1.5 Summary and Future Work: CHAPTER VI Overview
In the cerebral cortex, lateral migration of host cells is increased by lateral in-
terconnecting channels, but vertical migration is not enhanced by vertical channels
alone. Vertical organization of axonal transmission is eclipsed by the need to first
repopulate the defect cavity with cells from the lateral laminae, but microgrooves
and vertical channels could improve vertical organization of axonal projections in the
cavity once it is repopulated. In different animal models or different regions of the
brain, modifications can be made to the overall size, shape, and orientation while
maintaining the principle of interconnected channels and directed microgrooves.
In a thoracic spinal cord transection, entubulation is not necessary particularly
when the spine still partially provides a natural enclosure. Medial support of regen-
erating white matter tracts from the central core and outer shells prevents secondary
damage in the centralized gray matter, possibly because of neuroprotective effects of
regenerating nerve fibers and rostral nerve roots which are able to enter and bridge
the open defect site. More clinically applicable injury models in the spinal cord,
such as contusion or hemisection, could be accomodated with variations based on
the principles of anatomical structural support found here.
These are the first experiments using scaffolds made by indirect SFF techniques
to have designed architectures in CNS regeneration. They show that different macro-
scale architectures can affect tissue regeneration in the CNS, while micro-scale to-
pography is confirmed to affect cellular behavior in vivo. The contribution of this
work is to bring attention to the wide range of architectural possibilities for bioma-
terials in CNS regeneration. In addition to the delivery of neurotrophic factors and
cells, appropriately designed biomaterials can enhance the regenerative potential of
8
a defect site.
Because these architectures are created from a mold process, the material and
the method of generating micro-pores may be changed. Variation on these designed
architectures can be extensive. Each of the designs for these CNS injury models can
and should be combined with other tools for regeneration: neurotrophic factors, cells,
or extracellular matrix molecules. A prospectus on these combinations is included.
CHAPTER II
Background and Motivation
2.1 The nervous system: Disorders, injuries, and clinical treatments
The central nervous system (CNS) is comprised of the brain, and spinal cord.
Within this system is a control network for the many functions of the body. Humans
are most physically aware of the sensory and motor systems, that are controlled by
different regions within the CNS. On a cellular level, each of these regions and sys-
tems is made up of specific cell types. Neurons are largely responsible for the relay
of signals, action potentials, throughout the nervous system and physically carry the
information, most notably via their axons. The other cells in the CNS are glial cells
(astrocytes, oligodendrocytes, ependymal cells, and microglia the immune cells of
the brain) which vastly outnumber the neurons and are responsible for myelinating
the neurons and a host of other versatile functions. (For detailed information see
Principles of Neural Science Chapter 1, (Kandel et al., 2000)) The complexity of the
nervous system drives prolific research from the neuroscience community in an at-





The earliest studies of nerve regeneration date back to 1776 when William Cruik-
shank was studying the vagus nerves of dogs (Ochs, 1977). It was known then that
simultaneous bilateral vagus nerve transection resulted in death after a few days. In
a series of vagus nerve transection experiments varying the time between transec-
tions and also single vagus nerve transections, Cruikshank observed the breathing,
digestive behaviors, and time to death, followed by microscopic analysis of the dis-
sected nerves, and identified tissue connecting the two cut ends in some animals with
longer survival times. This connecting tissue was identified by simple microscopic
techniques to be similar to nerve tissue.
As the common occurrence of death became a problem in further study of pe-
ripheral nerve regeneration in the vagus nerve, the sciatic nerve became the favored
location for nerve regeneration studies with other scientists of the time, particularly
in cats, rabbits, and frogs (Ochs, 1977). By the 1800s it was generally accepted
that peripheral nerves could regenerate. Debate and research concerned only the
mechanism.
However, regeneration in the CNS, particularly in humans, was widely believed
to be impossible. Salamanders and newts, lower vertebrates, can regenerate spinal
cords readily, but until the mid 1900s there was a strong belief within the scientific
community that regeneration in higher vertebrates was impossible, and that research
to that effect was a waste of time (Windle, 1981). Though axons in injured spinal
cord, cerebral cortex, and optic nerve were described to undergo a period of abortive
sprouting before degeneration (Ramón y Cajal et al., 1991), it was concluded that
axons in the CNS were unable to regenerate beyond the abortive sprouting phase
because of the lack of Schwan cells, which seemed to improve the sprouting of axons
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in peripheral nerve (Ramón y Cajal et al., 1991).
The first suggestive evidence of regeneration in the spinal cord of higher verte-
brates was presented in 1940 with regard to immature rats which, after implanta-
tion of sciatic nerve grafts between severed spinal cord stumps, demonstrated some
anatomical, physiological and behavioral recovery in some of their animals (Sugar
and Gerard, 1940). This evidence was refuted by most scholars and not taken up
again until 1950 while studying central regulation of body temperature in cats and
dogs, a study which required transection of nerves at different levels, including the
spinal cord. After some period of time it was noticed that pain was sensed by dogs
upon bladder expression by the researchers (Windle and Chambers, 1951).
The National Paraplegia Foundation sought to increase the visibility of this type
of research and funding and support from governments by holding conferences (now
the National Spinal Cord Injury Foundation) which had rehabilitation medicine as
a strong alternative to regeneration research (Windle, 1981). It was then regarded
that without grafting or other techniques, spontaneous and complete regeneration
of severed axons could not occur in mammalian CNS. With the advancement of
analytical techniques and the increased interest in this research topic there now exist
several promising pathways of investigation for CNS regeneration (Windle, 1981;
Batchelor and Howells, 2003; Schwab et al., 2006).
2.1.2 Obstacles to regeneration in the central nervous system:
With the advancement of knowledge, it still remains that traumatic injuries in the
CNS very rarely regenerate compared to injuries in the peripheral nervous system
(PNS). Understanding and overcoming the large obstacles to regeneration in this
area are the motivations of basic scientists and engineers alike, and have motivated
the course of this dissertation.
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The PNS is made up mostly of axons extending from neurons in the spinal cord,
along with myelinating Schwann cells. When the PNS is injured Wallerian degen-
eration occurs (Rosenblueth and Dempsey, 1939), where severed axons die back
and nerve function and conductance is lost. The myelin sheath can be left intact
even after the axon has degenerated in vivo (Heath, 1982; Kidd and Heath, 1988a;
Kidd and Heath, 1988b; Kidd and Heath, 1991). This remaining natural channel is
sometimes able to guide axonal regeneration in the PNS with the help of neurotrophic
factors (Frostick et al., 1998), though complete functional recovery to pre-injury lev-
els remains unrealized.
Regeneration in the CNS is much more difficult. The differences between the
PNS and CNS reveal possible reasons for their difference in regenerative potential.
Schwann cells in the PNS normally myelinate axons but upon injury they can also
act as scavengers of cellular debris. Schwann cells, along with macrophages which are
activated by the complement cascade after injury, can clear an injury site of regenera-
tively inhibitory debris within several weeks (Hughes et al., 2002). In the CNS oligo-
dendrocytes do not clear debris during Wallerian degenerating, leaving macrophages
entering from circulation with a more delayed time course than in the PNS (Hughes
et al., 2002) to do this work. Instead, oligodendrocytes become reactive after injury,
upregulating the expression of transmembrane semaphorin Sema4D/CD100 and ver-
sican, both inhibitory molecules to axonal regeneration. It was earlier thought that
oligodendrocytes were passive during injury, and inhibitory molecules acted by virtue
of being released into the injury environment from physical damage. However the ac-
tive role of oligodendrocytes in axonal inhibition is now under investigation (Schwab
et al., 2005).
The cellular debris from the primary injury contains myelin inhibitory molecules
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such as Nogo-A and myelin associated glycoprotein (MAG). In normal tissue they
are present in myelin to help keep axons aligned in myelin sheaths, but released at
random into an injury site they also prevent axonal growth. Axons in the spinal cord
undergo Wallerian degeneration in the first 30 minutes of injury but will also attempt
to regenerate vigorously in the initial 6 to 24 hours after degenerating (Kerschen-
steiner et al., 2005). This type of regeneration was known to exist very early and
termed abortive sprouting (Ramón y Cajal et al., 1991). Inhibitory signals from ex-
tracellular matrix proteins like chondroitin sulfate proteoglycans (CSPG) produced
by proliferating activated astrocytes after injury (McKeon et al., 1991) and myelin
inhibitory molecules released from myelin and oligodendrocytes after physical disrup-
tion eventually overwhelm these axonal growth instincts and prevent any recovery
(Busch and Silver, 2007).
The inflammatory reaction, infiltration of macrophages, and scar formation are
much higher in spinal cord than brain (Trivedi et al., 2006), but follow a general pro-
gression. Neutrophils are the first invading inflammatory cells, within hours. They
phagocytose cellular debris and attract macrophages to do the same. However, neu-
trophils also release toxins and free radicals responsible for secondary tissue damage,
while macrophages, upon digestion of myelin debris, also store and provide choles-
terol for use in re-myelintation. Microglia, the resident inflammatory cells of the
nervous system, have many conflicting functions. Upon activation from injury, they
can remove myelin debris, promote neurite growth, decrease astrocyte proliferation,
and promote neuronal survival. They can also release free radicals and molecules
which damage tissue and inhibit regeneration (Trivedi et al., 2006).
Soon after the inflammatory cells are activated, astrocytes are activated, mainly
by the microglia. Astrocytes, microglia, and fibroblasts begin to proliferate and ac-
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cumulate at the injury site, depositing extracellular matrix to seal up the wound and
protect other regions from further damage, but also blocking regeneration (Schwab
et al., 2006; Maier and Schwab, 2006). This accumulation of cells and ECM is called
the glial scar, which particularly contains CSPG, produced by reactive astrocytes, a
molecule which inhibits axonal regeneration (Busch and Silver, 2007; Hermanns et
al., 2001). Though there are many obstacles to regeneration in the CNS, collateral
sprouting and re-routing of connections through spared tracts does occur, resulting in
spontaneous recovery of some function in a small number of cases (Kaegi et al., 2002;
Kerschensteiner, 2007). As the scientific community increases its understanding of
the CNS and its cellular and molecular mechanisms of injury and repair the infor-
mation will be of critical importance to the development of clinical treatments and
eventually cures.
2.1.3 Disorders and injuries:
There are a number of diseases which can cause varying degrees of damage to the
CNS. Neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and
multiple sclerosis are demyelinating diseases where myelinating cells of the CNS are
lost (De Carvalho et al., 2005; Miller, 2001). The causes are not understood but
patients lose motor control. Parkinsons disease (PD), on the other hand, results
from a loss of dopaminergic neurons and in many cases a larger parenchymal mass
loss (Singh et al., 2007). The most noticeable symptom of PD is tremor. Alzheimers
disease (AD) is marked by an abundance of neurofibrilary tangles and senile plaques
in the brain followed by loss of cholinergic neurons mainly in the basal forebrain, and
causes dementia (Jellinger, 2006).
Other insults to the CNS can result from an ischemic stroke, which deprives the
brain of oxygen and causes cell death in the brain, or traumatic injuries to either
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the brain or the spinal cord, which can cause a number of disabilities depending on
the location of injury. There are no cures for CNS injuries or diseases. Currently,
treatments are largely palliative.
2.1.4 Clinical treatments:
The disorders and injuries of the CNS are not only incurable, but lack adequate
long-term treatments. The devastating and seemingly hopeless prognoses of these
conditions is the motivation for tissue engineering research in the CNS, including
this dissertation.
There are a number of pharmacological treatments for PD which essentially boost
or replace dopamine in the brain, treating the symptoms but requiring increased dos-
ing over time and eventually becoming inadequate. Surgical removal of brain tissue
is a last resort due to complications and inefficient long-term control of symptoms.
There is ongoing research on neuroprotective agents to prevent PD onset in high-risk
individuals based on family history. Deep brain stimulation has made some inter-
esting improvements for a specific subset of patients with PD and essential tremor
(Singh et al., 2007) but all PD patients are still waiting for a cure. ALS and AD
patients have a similar prognosis. Pharmacological treatments are unable to halt or
reverse the disease progression.
Methylprednisolone has been administered for acute spinal cord injuries (SCI) in
the first 8 hours of injury with mixed results for improving outcome and recovery
by reducing secondary damage (Bracken et al., 1984; Bracken et al., 1990; Hall
and Braughler, 1982). Two national clinical trials showed benefit in humans but the
analytical methods have been challenged (Coleman et al., 2000; Hurlbert, 2000; Short
et al., 2000; Tsutsumi et al., 2006; Tator, 2006; Leypold et al., 2007). Regardless of
the methods for showing significance, its use does not repair the primary injury.
16
In the case of traumatic brain injuries (TBI), brain tissue undergoes a healing
process which includes necrosis and/or apoptosis in regions originally undamaged
(Williams et al., 2006; Raghupathi, 2004). A summarized comparison of the following
injury models in rats, penetrating ballistic-like brain injury (PBBI), stab wound,
lateral fluid percussion (LFP), cortical concussive injury (CCI), and middle cerebral
artery occlusion (MCAO) (which approximates ischemic stroke), ((Williams et al.,
2006) table 4) reveals that, due to physical trauma, there is generally some degree of
hemorrhage. The greatest amount of hemorrhage occurs in PBBI. After the first day,
when cells are disrupted and die of necrosis to form an initial injury, the lesion volume
grows over the next 2-3 days as microvasculature in the perilesional area is disrupted
and secondary cell death occurs, presumably due to local ischemic conditions. In
MCAO, this secondary death can continue for several more days into a full week
and reaches the largest lesion volume. Remote white matter injury, likely apoptotic,
and macrophage infiltration occur in all these models anytime between the first
few days and beyond two weeks. There are indications for surgical treatments to
lessen potential secondary damage and to improve chances of survival after traumatic
brain injuries. Clinical evidence suggests that surgical treatment such as craniotomy
or evacuation of hematoma may improve outcomes in severe TBI that consist of
parenchymal mass lesions and neurological dysfunction, particularly when defect
volume is greater that 50 cm3, or 20 cm3 when accompanied by a midline shift of at
least 5 mm and/or cisternal compression on CT scan (Bullock et al., 2006). The most
common reason for surgical intervention is to decrease intracranial pressure. With
or without surgical treatment, secondary cell death after the first day continues to
be a problem.
Though current treatments for CNS disease and injury can hope only to prevent
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further damage or slow the disease progression, the field of tissue engineering aims to
generate functional tissue and repair both primary and secondary damage. This is a
significant proposal, as the difficulty is great. However it is also significant because
the potential benefits are great and also a fundamental motivation for this body of
work in CNS regeneration.
2.2 Past central nervous system repair strategies
The basic techniques behind tissue engineering involve some combination of bio-
material scaffold, cells, and biologic cues such as trophic factors or substrate in-
teractions (Langer and Vacanti, 1993). A recent review of experimental strategies
specifically for spinal cord regeneration outlines five strategic categories: 1) neu-
roprotection for diminution of secondary damage by targeting the innate immune
response of neutrophils, macrophages and the like 2) neurorestoration by remyelina-
tion and restoration of conduction through de-myelinated tracts 3) neuroregeneration
by antagonisation of inhibitory factors like CSPG or Nogo-A or neuroregeneration by
promoting axonal growth factors (neurotrophic factors) 4) axon guidance to specific
sites of deafferation and 5) neuroreconstruction with cell and tissue transplantation
(Schwab et al., 2006). The following is a brief summary of current lines of scientific
investigation in general CNS regeneration. Rather than by strategy, as they can
vary for different regions of the CNS, they are categorized by tools for CNS repair
to better highlight the focus of this dissertation and when appropriate are described
in relation to this work.
2.2.1 Cell sources
Replacement cells from various sources are being investigated for treatment of
diseases and injuries of the nervous system. Cell types in use fall primarily into one
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of the following categories: Embryonic Stem Cells (ESC), Neural Stem Cells (NSC),
Schwann Cells (SchC), Olfactory Ensheathing Cells (OEC), and Bone Marrow Stem
Cells (BMSC) or Mesenchymal Stem Cells (MSC).
ESC from the blastocyst stage of the developing embryo can be differentiated into
multiple neural lineages, including neural progenitor cells similar to NSC (Tabar and
Studer, 2002). These cells, differentiated or not, have been investigated for use in
treating many nervous system disorders including SCI (McDonald et al., 2004), PD
(Ben-Hur et al., 2004), and ischemic brain injury (Takagi et al., 2005). Research
pertaining to them is currently limited by regulatory restrictions on ESC derivation
and poses a barrier within the US.
Aside from ESC derived neural progenitors, NSC can be isolated from the sub-
ventricular zone of the hippocampus among other locations of the CNS (Doetsch
et al., 1999; Temple and Alvarez-Buylla, 1999), and have also been shown to im-
prove recovery in TBI (Shear et al., 2004), ischemic brain injury (Lee et al., 2007;
Park et al., 2002), intracerebral hemorrhage (Lee et al., 2007), and SCI (Teng et
al., 2002). The limitations for these cells lie in the difficulty of obtaining them from
patients or donors.
SchC are myelinating cells of the Peripheral Nervous System (PNS). Their coun-
terpart in the CNS is the oligodendrocyte. SCI has been most successfully treated so
far with peripheral nerve grafts (Levi et al., 2002; Houle et al., 2006; Kuo et al., 2007;
Dinh et al., 2007), whose SchC are able to re-myelinate CNS axons (Fukunaga et
al., 2004). Because of this ability, SchC have been isolated from peripheral nerve
biopsies (Salzer and Bunge, 1980; Morrissey et al., 1991) and cultured for implan-
tation as a purified and expanded population in CNS repair (Martin et al., 1996;
Pearse et al., 2004; Brook et al., 2001; Pinzon et al., 2001; Dinh et al., 2007;
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Evans et al., 2002; Hurtado et al., 2006; Stokols et al., 2006). Though not a re-
placement for neurons of the CNS, they provide a beneficial environment which
could enable the intrinsic neural progenitor cells to repopulate and regenerate the
injury.
OEC are similar to SchC but can be isolated from the olfactory system, part of
the CNS, via nasal biopsies in humans (Barnett et al., 2000; Feron et al., 2005). A
component of a relatively regenerative region of the CNS, these glial cells are also
able to re-myelinate regenerating axons in the CNS and improve functional recovery
(Imaizumi et al., 1998; Ibrahim et al., 2006; Raisman, 2006; Barnett and Riddell,
2007).
BMSC or MSC are isolated from the bone marrow (Krebsbach et al., 1999). MSC
are considered to be a purified stem cell population, while BMSC are considered
a heterogeneous population from the bone marrow. Some studies show that these
cells express neural markers and can take on similar morphologies after different
treatments (Woodbury et al., 2000; Woodbury et al., 2002; Munoz-Elias et al., 2003;
Munoz-Elias et al., 2003; Coyne et al., 2006; Keilhoff et al., 2006), but their ability
to take on neural cell roles is controversial (Spyridonidis et al., 2005; Pauwelyn and
Verfaillie, 2006). Though not often regarded as potential replacement cells, they have
been shown to improve outcomes in CNS injuries (Nandoe et al., 2006) likely due
to neuroprotective effects and secreted neurotrophic factors which alter the injured
environment (Lu et al., 2007; Mahmood et al., 2003; Lu et al., 2002; Chen et al., 2002;
Lu et al., 2001; Mahmood et al., 2001; Mahmood, 2002; Mahmood et al., 2002;
Mahmood et al., 2004a; Mahmood et al., 2004b). They are the subject of several
studies in CNS repair and should certainly be held as an important tool to investigate
(Sykova et al., 2006b; Sykova et al., 2006a; Mahmood et al., 2005; Mahmood et al.,
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2006; Mahmood et al., 2006b; Mahmood et al., 2006a).
Cells of any type have not been able to fully repair damaged CNS, and some also
carry the caveat of potential tumor formation. They have a low survival rate when
injected in vivo without any carrier and will most likely be used in combination with
other tools for repair.
2.2.2 Trophic factors and extracellular matrix proteins
Neurotrophic factors such as nerve growth factor (NGF), brain-derived neurotrophic
factor (BDNF), and neurotrophin-3 (NT-3) have long been known to strongly influ-
ence development of the CNS, and also to enhance different neuronal cell growth.
Their influences on specific cell types are varied and not completely understood
(Thoenen, 1991; Hyman et al., 1991). Their combined use in current investigations
with other reparative tools, particularly cells, is an indication of how important they
will be in the repair of damaged CNS (Houle and Ziegler, 1994; Bakshi et al., 2004;
Piantino et al., 2006; Stokols and Tuszynski, 2006; Lu et al., 2007). However, the
field of controlled release exists for the purpose of delivering small molecules such as
neurotrophic factors over an extended period of time, longer than they would persist
in vivo if they were just injected. These factors will likely not be effective without a
material vehicle to carry them.
Extracellular matrix (ECM) proteins, peptides which mimic cell attachement do-
mains in the ECM, and nano- or micro-structured materials which mimic the ECM
architecture (Ellis-Behnke et al., 2006) are of interest in tissue engineering applica-
tions because of their encompassing influence on cell behavior (Larsen et al., 2006).
Fibronectin (FN) is one of the key proteins involved in cell adhesion and migra-
tion throughout the body. Its attachment mechanism, based in integrin binding,
is found in a short peptide sequence of arginine, glycine, and aspartic acid (RGD)
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(Pierschbacher and Ruoslahti, 1984). This peptide sequence has been used to func-
tionalize numerous materials for biotechnology applications (Hersel et al., 2003). The
FN protein itself is often adsorbed to materials to increase cell attachment, though
the material properties affect its conformation when adsorbed (Lhoest et al., 1998;
Keselowsky et al., 2003), which in turn affects its signaling capabilities with cells
(Miller and Boettiger, 2003) and their strength of attachment and spreading (Iuliano
et al., 1993). For the most part, FN is used in neural tissue applications to influence
glial cells and indirectly influence neurons (Ahmed and Brown, 1999), though it may
play a critical role in axonal extension from adult white matter (Tom et al., 2004).
Laminin (LN) is found in the basement membrane and has the most significant in-
fluence on neural cell alignment, neurite extension, and growth cone guidance (Luck-
enbillEdds, 1997; Kuhn et al., 1998). It is often included in studies for nerve regener-
ation and guidance, improving experimental outcomes in vitro (Recknor et al., 2004;
Wen and Tresco, 2006; Attiah et al., 2003; Miller et al., 2001; Thompson and Buet-
tner, 2001; Stabenfeldt et al., 2006) and in vivo (Hou et al., 2005). A peptide
sequence responsible for the attachment and neurite extension properties of LN was
also identified (Tashiro et al., 1989; Nomizu et al., 2000) and is being used in con-
junction with a hydrogel to promote regeneration in the rat cerebrum (Cui et al.,
2003). Though it seems that LN is the protein of choice for neurons, its peptide
sequence does not support stem cell adhesion and differentiation in vitro (Saha et
al., 2007).
Since cell signaling cascades and their control over cell phenotype and behavior
can be influenced by the extracellular matrix and the cell-material interface, these
cellular level material considerations will be essential to reparative strategies. Also
because of their contact-dependent nature, a biomaterial scaffold will be integral in
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their use for CNS regeneration.
2.2.3 Topographical cues and patterned substrates
The morphology of a surface, roughness or smoothness, on which cells are cul-
tured has a great effect on the cellular and tissue interactions independent of the
chemical characteristics of the material (Singhvi et al., 1994). Rough surfaces on
implants have greater integration with bone, and less fibrous tissue encapsulation.
Though the early information on these effects was not systematic with regard to sizes
and shapes of roughness, there was a clear idea that different tissues and cell types
reacted differently to different surface topographies. With the advancement of fabri-
cation techniques, scientists are able to study the effects of controlled topographies
of materials on cell growth and tissue interactions (Curtis and Wilkinson, 1997).
Topography can take on a large range of shapes and sizes, from pits and hills,
holes and spikes, to stepwise or V-shaped linear or circular grooves. An early study
of surface roughness compared to smoothness of the inner lumen of a guidance tube
for peripheral nerve regeneration showed that random pored roughness on the order
of 100µm resulted in a fibrous tissue filled channel with few regenerating myelinated
axons compared with a smooth inner lumen. Though the smooth guidance tube
contained greater numbers of myelinated axons, they were not attached to the inner
lumen of the tube, while the rough lumen was well integrated with the infiltrating
fibrous tissue (Aebischer et al., 1990). But by far the most interesting topograph-
ical feature for neural tissue repair is linear grooves for alignment and extension
of neurites. Many variations on groove width, depth and plateau width have been
generated and many cell types have been cultured in vitro to study their behavior.
Studies of chick embryo neurons in vitro revealed that with fixed groove widths
at 8µm and ridge widths at 20µm, a groove depth of 1µm elicited no alignment of
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neurites, while at 2µm depth alignment was achieved, indicating a lower limit on
feature size for neurite alignment (Clark et al., 1990). This was further supported
when nanoscale features for groove width, depth, and ridge width were created and
no alignment was achieved with neurites, while fibroblasts and endothelial cells were
still sensitive to alignment cues (Clark et al., 1991). Nanoscale features are indeed
very influential in osteoblast and osteoclast alignment (Ito, 1999), and meningeal
cells along with their extracellular matrix (Manwaring et al., 2004) while for neurons
it seems micron-scale features are more effective. Furthermore, an upper limit for
neurite alignment seems to exist around the tens of microns, as grooved substrates
coated with LN yielded higher percentages of aligned neurites in vitro with narrower
ridges: 30µm being better than 200µm (Miller et al., 2002), and 10µm being better
than 20µm (Goldner et al., 2006).
Indeed it seems that the constraint based on cell size and confinement to a con-
tinuous ridge has a great affect on neurite alignment. Particularly with increasing
groove depth on single to tens of microns scale, the narrower the groove and ridge
(while still above single micron scale), the more concentrated the focal adhesions are
to the ridge, thus aligning the cytoskeleton with the grooved features (Ito, 1999).
However, another study of dorsal root ganglion (DRG) neurons puts the upper limit
for alignment at 10µm with a depth of 50-100nm (Tsuruma et al., 2006), a depth
which was previously unable to affect chick embryo cerebellum neurons (Clark et
al., 1991). It might indicate that different types of neurons have different behaviors
due to topography. However, with this study the groove and ridge materials were
glass and poly(ε-caprolactone) with a poly-lysine coating (Tsuruma et al., 2006).
These two materials have the added possibility of affecting the poly-lysine adsorp-
tion properties and varying the effects of this cell adhesive molecule on the cells,
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making some of these observations due to chemical, not topographical, cues. The
subject of patterned physico-chemical properties on substrates is another avenue of
controlling directional growth and migration of cells which will not be discussed here
(Ito, 1999). An in vitro study of DRG explants cultured at the ends of polypropylene
multifilament bundles with varied diameters showed that filaments with 5 and 30µm
diameters had greater neurite extension and SchC migration than larger diameters
of 100, 200, and 500µm, a difference which was amplified when filaments were coated
with FN, and even more so with LN (Wen and Tresco, 2006).
Thus far there have been no in vivo comparisons of topographical features and
sizes, but the small nuances in feature size influences found in vitro with single cell
cultures could well be lost when transferred to in vivo studies. In the experiments de-
tailed in this dissertation the focus was on macro-scale architecture. Thus micro-scale
topography was generally fixed and justified based on the in vitro studies outlined
above. When micro-scale grooves (microgrooves) were incorporated into scaffolds,
they were uniformly in the range of 30-50µm with V-shaped profile, thus the grooves
and ridges were of tapered width. The tapering could be considered a compromise
between the various size limits ranging from single to tens of microns. The orien-
tation with respect to different axes is the only aspect varied between experimental
groups, and details of these can be found in each chapter.
2.2.4 Mechanical properties and neural cell behavior
Aside from the topographical properties, materials also have mechanical prop-
erties which are important in all tissue types from bone to brain. Much work is
focused on hydrogels because of their comparable mechanical properties to the bulk
properties of the nervous system, soft. There are several very specific measurements
of different moduli (shear (Darvish and Crandall, 2001), tangent (Fallenstein et al.,
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1969), compressive (Miller and Chinzei, 1997)) and permeabilities (Linninger et al.,
2007) for different parts of the nervous system (white matter, gray matter (Coats
and Margulies, 2006; Prange and Margulies, 2002), pia mater (Aimedieu and Grebe,
2004), spinal cord (Fiford and Bilston, 2005), brain (Miller and Chinzei, 2002))
mostly intended for finite element analysis and models for surgical planning. How-
ever, developing materials with this level of detail can be quite challenging, and the
need for exact matching is unknown. Some studies have shown improved neurite ex-
tension in softer collagen gels than stiffer (Willits and Skornia, 2004). Another study
shows neurons behave similarly in all stiffnesses of polyacrilamide or fibrin gels yet
astrocytes attach, spread, and organize their cytoskeleton better on stiffer materials
(Georges et al., 2006). They contend that use of a softer gel would increase the ratio
of neurons to astrocytes in a regenerating population. However, it is also possible to
design composite implants with a soft hydrogel embedded within a relatively stiffer
scaffolding which could enhance astrocytic infiltration to provide its natural matrix
support while allowing neurons to grow within the hydrogel in the matrix. This is a
future application envisioned with the macro-architectural design hypothesis of this
dissertation.
Various scaffold types have been investigated for CNS repair, mostly related to
SCI. Though they fall within current strategies for CNS repair they will be discussed
in the next section on macro-scale architectural influences and how they relate to
the problem statement for this dissertation.
2.3 Macro-scale architectural influences and potential uses
We know on a cellular scale that topological cues and chemical and molecular cues
are important and can influence cell survival, growth, and phenotype. The general
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hypothesis for this dissertation is that architecture on a larger scale can affect tissue
growth in the CNS. When one is no longer in vitro but rather in vivo, the system
of evaluation is the whole tissue. If the architecture of a scaffold on its own is able
to improve the regeneration potential in the CNS, its use would enhance the effects
of other combination treatments like neurotrophic factors or implanted cells. Use of
appropriate architectures could also potentially decrease any dosing requirements for
expensive or limited treatments such as recombinant proteins or autologous cells. It
is thus hypothesized that creating a more diverse set of macro-architectures based
on known anatomical characteristics of the tissue would improve the regenerative
capacity of the CNS.
This architectural question is easily discussed for skin, which has an obvious aspect
ratio for its regeneration, and vasculature which is tubular. Bone has a need for
porosity to encourage ingrowth, while providing mechanical support. One might
argue that the tube or cylinder is already the obvious anatomical shape for the
spinal cord but other architectures have not been investigated though a cylindrical
scaffold with detailed channels for specific fiber tracts has been proposed (Friedman
et al., 2002). The majority of regenerative work in nervous tissue began in peripheral
nerve repair, as its propensity to regenerate is greater, and its natural architecture
is similar to vasculature: tubular, with a longer aspect ratio than the spinal cord.
The use of guidance tubes in SCI studies is no doubt a translation from its use in
peripheral nerve repair studies. The brain has no history of this type of discussion,
and is admittedly more difficult than the spinal cord as its organization and fiber
tracts are so complex and varied. The following subsection is a review of materials
and macro-architecture recently applied to CNS regeneration and their benefits and
pitfalls. Because there are so many examples of materials fabrication with the intent
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of SCI repair, the following summary will include only those with accompanying in
vitro or in vivo study with neural cells or tissues, and focussing mainly on in vivo
studies. Fabrication techniques for materials will not be discussed in detail unless
directly relevant to the work done for this dissertation.
2.3.1 Scaffolds for brain injury repair
Most studies of biomaterials for use in brain trauma involve the use of hydrogels
which can be injected into a cavity and take on the shape and size in situ with no
predesigned macro-architecture. Hyaluronic acid hydrogels have been investigated
with some neural adhesive functionalization such as LN (Hou et al., 2005) or poly-d-
lysine (Tian et al., 2005a) and improve cellular infiltration, neural tissue integration,
and neurite extension into the gel compared to the gel without modification. Col-
lagen gels, which alone do not support regeneration, when mixed with FN aid in
neural stem cell (NSC) survival when injected into injury cavities (Tate et al., 2002).
Another hydrogel, methyl-cellulose, injected alone into rat brain is biocompatible in
the brain, though it gives no benefit either (Tate et al., 2001). A non-degradable
hydrogel, poly N-2-hydroxypropyl-methacrylamide (pHPMA), functionalized with a
peptide sequence for the adhesive and neurite promoting region of LN, improves the
angiogenesis and axonal growth into this hydrogel in vivo (Cui et al., 2003).
Aside from injectable hydrogels, synthetic degradable implants have also been
implanted. A woven mesh of poly(glycolic acid) (PGA) fibers of 10-15 µm diamters
was used to culture NSCs in vitro. The architecture was random with micro-scale
features from the fibers. This material and cellular composite was implanted into the
injury cavity of rats after a hypoxic ischemic event (Park et al., 2002). The implant
was able to support tissue integration and improvement of neurological function, and
reduced secondary damage, mostly attributable to the presence of NSC. PGA is a
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quickly degrading member of a family of polyesters (poly-α-hydroxy acids) commonly
used in tissue engineering applications. An in vitro study of the biocompatibility of
three related polymers, poly(lactic-co-glycolic acid) (PLGA, 75:25), poly(L-lactide-
co-ε-caprlactone) (PLCL), and poly(L-lactide acid) (PLLA) on NSC determined that,
of the three studied, PLGA supported greater viability, neuronal differentiation,
metabolic activity, and less apoptotic activity. PLGA and its related polymers have
been used in SCI applications as well and will be discussed in the next subsection.
No studies have been conducted on macro-scale architectural effects on brain tissue
repair in vivo. Indeed, hydrogels are often unable to maintain macro-architectures,
or they would need a higher concentration resulting in a higher stiffness and lower
diffusivity. A scaffold similar to the mesh fibers just discussed could also be impreg-
nated with a hydrogel, yet hold the entire composite within a macro-architecture.
Because of the need to maintain an architecture, these types of implants could not
be injected through minimally invasive techniques. However, in some cases of brain
injury, craniotomy is used for reducing intracranial pressure, evacuating hematomas,
or due to severe trauma the cranium is already damaged and should be removed
from the interior cavity. In these cases an implantable scaffold might be a useful
method of treating the injury, rather than an injectable hydrogel, since the cranium
is already open and one can keep a scaffold spatially localized better than a semi-fluid
hydrogel.
2.3.2 Scaffolds for spinal cord injury repair
There are several reviews of biomaterial strategies in spinal cord injury (Novikova
et al., 2003; Zhang et al., 2005; Karp et al., 2003; Friedman et al., 2002; Hadlock and
Sundback, 2006; Nomura et al., 2006). Because of the focus of this dissertation, the
use of materials which cannot be formed into specific macro-architectures will be left
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out of the background discussion for SCI. Hydrogels such as fibrin, collagen, agarose,
hyaluronic acid, and Matrigel, which have been used in their hydrated gel-like state
for injection or as a surgical implant with no other form of overall architecture
will not be discussed. If they have been additionally processed to impart greater
structure, such as freeze drying or used in conjunction with another material as a
composite implant, they will be included here. Aside from gels, general architectures
of note can be grouped into the following categories: random pored cylinder, tubes,
multichanneled cylinders, and multifilament bundles. A poly(D-L-lactic acid)(PLA)
and solvent mixture was freeze-dried to form a very porous foam whose pores were
unidirectionally oriented and ranged in size from roughly 10 to 150 µm. This foam
was cut into a cylindrical rod 4mm long and 2.6 mm in diameter and filled with a
fibrin gel. In a transection model in rat, these foam cylinders did not support axonal
growth into them. Adding BDNF by embedding with fibrin gel, axonal growth was
marginally increased (Patist et al., 2004). These same cylinders, seeded with SchC
which were transduced to secrete a BDNF/NT-3 multifunctional protein, had low
cell survival and there was no difference in functional improvement with or without
cells or polymer cylinder implant. A cylinder of randomly spaced oriented porous
material was not beneficial, nor did it support survival of implanted cells (Hurtado
et al., 2006). This PLA material was also then used to make porous tubes instead of
cylinders, then filled with SchC. These implants were able to support small cables of
regenerating neural tissue but collapsed after a few weeks, breaking into pieces and
disrupting the tissue (Oudega et al., 2001).
In a similar freeze-drying method to the PLA cylinders (Patist et al., 2004),
agarose gel was freeze-dried with dissolvable filament bundles interspersed to create
a multichannel scaffold with additional isotropically oriented porosity in the bulk of
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the material. This channeled agarose scaffold was used in a C4 hemisection model
with recombinant BDNF (Stokols and Tuszynski, 2006), or BMSC transduced to
express BDNF (Stokols et al., 2006). In part due to the hemisection rather than
transection model, there was very linear axonal regeneration through these channels,
additionally enhanced by the biological factors incorporated.
A non-degradable material, poly-acrylonitrile-poly-vinylchloride (PAN-PVC), was
use to make tubes 8mm long and 3 mm diameter. These were also filled with Matrigel
seeded with SchC. These scaffolds were cultured in vitro with SchC embedded in
Matrigel until a bridge of aligned cells was formed. The distal end of the tube was
capped, and after implantation at a T8 transection there was propriospinal axonal
regeneration after one month into the tube from the proximal end (Xu et al., 1995b)
which was improved with inclusion of BDNF and NT-3 (Xu et al., 1995a), and
also with the administration of methylprednisolone at the time of surgery (Chen et
al., 1996). When the distal end was uncapped and both ends of the tube were open,
axons grew into both ends of the tube after one month, but the entering axons did no
exit on the distal end into the stump (Xu et al., 1997). These tubes were then made
smaller, 3 mm long and 1.25 mm diameter, with SchC bridges. They were placed in a
hemisection model, rather than entubulating a complete transection model. Greater
ingrowth and integration with the spared host tissue was seen and axons entered
and exited the tube to form a continuous connection across the hemisection (Xu et
al., 1999). The larger complete transecion scaffolds were then implanted for three
months and evoked potentials were generated in two out of nine animals, stimulating
from within the scaffold and measuring 1 cm distal in the defect (Pinzon et al., 2001).
Control tubes with just Matrigel and no cells did not generate any evoked potentials
or support axonal regeneration in any of these studies. In all these studies, SchC or
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neurotrophic factors were the main cause of any improvements.
Poly(lactic-co-glycolic acid) PLGA (85:15) was used in different fabrication tech-
nique to created a cylinder with 7 channels of 450 or 600 µm diameters. The walls of
the channels were made porous from solvent evaporation (Moore et al., 2006). These
scaffolds were seeded with SchC to induce axonal regeneration in a transection model
as well. While they had no axonal regeneration within the scaffold without SchC
implantation, they demonstrated an injection molding fabrication technique which
could be modified to change the number and diameter of channels. Their scaffolds
were designed for use as a template for the arragment of cells to attract and guide
axons. However, they also discussed the potential of very specific tubular designs in-
corporating individual shapes and sizes of different white matter tracts and building
of a mold by free-form fabrication techniques, though a scaffold was not built from
this mold, presumably because of the fine detail and delicacy of the mold (Friedman
et al., 2002). Though these authors suggest that the locations of cells would be im-
portant, thus varying the scaffold architecture for reasons of placement of cells would
be important, they do not suggest that the architecture of the material itself would
have an effect on nervous tissue regeneration.
Poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) (pHEMA-MMA) is a
non-degradable material used for contact lenses. It is a hydrogel able to maintain
its architecture. It is the subject of several studies in SCI. Tubes with two different
elastic moduli (177 kPa and 311 kPa) were made of this material and implanted
in a complete transection without any filler or biological cues. Axonal regenera-
tion was seen within these tubes, and to a greater extent in the 311 kPa tubes
(Tsai et al., 2004), in contrast to other studies with different materials previously
discussed where no regeneration occured unless SchC or neurotrophic factors were
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incorporated. Though the pHEMA-MMA tubes may have had a slightly smaller gap
between transected stumps, this study highlights the potential benefits of material
and architectural designs prior to addition of biological factors. These tubes were
then studied with different hydrogel matrices (collagen, fibrin, Matrigel) and neu-
rotrophic factors (FGF-1, NT-3) as well as 4 smaller tubes within the larger channel
(tubes within channels, TWC) to create a channeled scaffold with greater surface
area. The TWC improved funcitional recovery over the empty single tube, and also
over some of the other groups containing matrix and neurotrophic factors (Tsai et
al., 2006). Some vestibular and reticular brainstem motorneurons were also found
regenerating within the TWC. This study also calls attention to the possiblity of
different types of matrices to encourage regeneration of different types of axons and
neurons. What is most interesting in these studies is the affect of TWC compared
to an empty tube. The changing of the scaffold architecture, and thus surface area,
affected the regeneration and functional recovery to a measurable extent.
However, the authors later mention that some of their tubes collapsed during
the experiments (Nomura et al., 2006), an event also documented with the previ-
ously discussed PLA tubes (Oudega et al., 2001). They then reinforced those tubes
with denser coils of the same material, but did not continue study of the TWC. In-
stead they placed these reinforced pHEMA-MMA tubes in a spinal cord transection
with and without a peripheral nerve graft and FGF-1 incorporated inside the tube
(Nomura et al., 2006). The addition of SchC and FGF-1 did not improve results
compared to the empty reinforced tube, and additionally the results for these tubes
were worse than previous non-reinforced implants. This is in contrast to the many
studies already discussed where SchC and neurotrophic factors significantly improved
outcomes with other material scaffolds. Entubulation methods involve placing the
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stump ends inside the tube scaffold.They note that possibly the tubes were too small,
pinching the stumps and causing syringomyelia and caudal migration of the rostral
stump. This difference in results suggests that architecture could be quite important
in the regenerative and reparative conditions, and the effectiveness of biologics.
Of the scaffold types discussed for SCI, the random pored cylinder and smaller
tube for hemisection, and multichannel cylinders do not involve potential constriction
of transected stumps as entubulation methods do. Another scaffold type which is
non-constricting and also incorporates micro-scale linear topographical cues is the
multi-filament bundle.
Cylindrical bundles of 10,000 5µm diameter carbon filaments were implanted in
5mm long spinal cord transections and shown to integrate into the spinal cord tis-
sue and support axonal guidance (Khan et al., 1991). These filaments were within
the range of feature sizes described to align neurons in vitro as described in the
previous section. More recently, 4000 collagen type I filaments of 20µm diameter
were bundled and implanted in 5mm defects and were able to integrate into the
tissue and improve functional outcomes as measured by BBB scores (Yoshii et al.,
2003). Furthermore, these researchers compared those longitudinally aligned bun-
dles to bundles of collagen fibers aligned perpendicular to the rostro-caudal axis and
found poor recovery and integration (Yoshii et al., 2004), indicating the longitudinal
alignment of micro-scale features to be important in vivo. However, they did not
vary the macro-architecture, using only a bundled geometry within a tube.
2.3.3 Designed architectures in the central nervous system
Some researchers have already agreed that designed architectures can be used as
tools in CNS regeneration, specifically for spatially localizing specific cells (Moore et
al., 2006; Friedman et al., 2002) or different tubes containing different neurotrophic
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factors (Tsai et al., 2006). Topographical cues could be strategically placed to aid
in axonal guidance. Insightful architectural design could provide structural sup-
port from collapse while impeding scar tissue impingement and preserving a region
for regeneration and vascularization. There are many conformations which can be
imagined for CNS repair. The main obstacle is often fabrication techniques.
Fabrication methods: One method developed for fabrication of designed scaf-
folds in tissue engineering has been solid free-form fabrication (SFF) (Hutmacher et
al., 2004). A wide variety of 3-D designs can be made with various computer soft-
ware, including Rhinoceros (McNeel North America, Seattle, WA). Different SFF
techniques exist: selective laser sintering, sterolithography, 3-D wax printing. Scaf-
folds can be made directly or indirectly through molds built by SFF techniques
(Hollister, 2005). A 3-dimensional object file is generated which can be separated
into a stack of 2-dimensional layers with an intended nominal thickness. With a
3-D printer, each 2-D layer is printed on a stage in a wax-like material to generate
a raised 2-D cross-section of the 3-D object. Each layer is printed on top of the
next as the stage lowers the printing surface by the layer thickness and trims the
previously printed layer to the appropriate thickness. Through this layer-by-layer
printing method, features as low as 250-300 µm can be created with great accuracy.
Additionally, at the object’s surfaces a groove is created between each layer which
is the size of the layer thickness printed. Orientation of these aligned grooves on
the object surfaces can be changed by changing the orientation of the object as it is
built.
With the information on the importance of topographical cues and intrinsic anatom-
ical structure and the capabilities for detailed fabrication from SFF techniques, a
wider range of architectures can be investigated.
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Designed scaffolds made for the work presented in this dissertation were made in
molds built on a 3-D printer. A salt leaching technique was used (Mikos et al., 1994)
to cast a porous polymer into the mold. Poly(ε-caprolactone) was used in all designed
scaffolds so that the scaffolds would be porous and strong, yet soft and compressible.
Between 65-85% porosity, the compressive strength of salt leached PCL is on the
order of 100-250 kPa and the compressive modulus 500-1000 kPa (Olah et al., 2006).
Details of fabrication will be described in the following chapters. Briefly, molds were
designed in Rhino and built on a 3-D wax printer. Molds were packed with size-
sieved salt crystals prior to polymer casting to ensure interconnection of the salt
crystals and therefore pores. If salt is mixed with the polymer solution, salt crystals
can potentially become encapsulated in polymer. Polymer was dissolved in warm
acetone and poured into the salt-packed molds. Acetone was allowed to evaporate
overnight and wax mold was dissolved in BioAct solvent, then salt and BioAct were
removed with several washes of 70% ethanol.
Anatomically inspired designs: The organization of the central nervous sys-
tem varies from location to location, thus to begin designing architectures based
anatomical organization one must first choose locations. The cerebral cortex and
thoracic spinal cord of rat have undergone investigation in the past with focus on
traumatic brain and spinal cord injuries and are chosen here to continue in that vein.
The organization of the cerebral cortex, a gray matter region, is conserved quite
well over the vertebrate species. (Figure 2.1) The mature thickness is generally a
few millimeters, 3-4 in humans, 2-3 in rodents. The thickness can be subdivided
into six transverse or horizontal layers which contain different subsets and combi-
nations of neurons. They can be broadly categorized as projection neurons or local
interneurons. Though the layers are not physically separated, there are pathways
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that connect specific layers to other regions of the cortex and also to deeper regions
of the brain like the thalamus. Additionally, neurons connect horizontally with each
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Figure 2.1: A schematic diagram of rat and human brain in coronal cross-section with cerebral cortex organization
highlighted. Not to scale, the cerebral cortex (dark purple) in rat and human are roughly the same
thickness. Due to the increased surface area of the human brain, there are more cortical columns,
bundles of neurons forming a unit for processing information (dashed boxes), even though the size of
individual columns is the same between species.The layers within the columns contain different types
of neurons or the dendrites or axons and synapses from cells of other layers or parts of the brain.
Axons project vertically, perpendicular to the pial surface, while the different cell layers are oriented
horizontally.
Functionally, the cortical neurons are organized and communicate in bundles
called cortical columns (Figure 2.1). These columns run vertically, perpendicular
to the surface of the cortex or the pial surface depending on the presence of wrin-
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kles. Neurons in these columns extend their axons and dendrites vertically to connect
with each other from layer to layer across all six layers and also horizontally for much
shorter distances to communicate within the column. The diameters of these columns
are 300-600 µm in diameter, a size also conserved across species (Mountcastle, 1997).
Evolutionary expansion of the cortex is accomplished through increasing the surface
area through the number of cortical columns, not the size of the individual columns.
Thus a primate or human can have a cerebral cortex much like rodents, made up of
the same sized columns and roughly the same thickness of cortex, but with large gyri
and sulci and a greater volume to cover. Rats have a fairly smooth cortex, not wrin-
kled like humans. Since the cortical neurons are organized in two ways, 1) horizontal
layers of specific neuronal cell types and long distance communication and 2) verti-
cal cortical columns of local communication and axonal projections, these linear and
orthogonal directions could be imitated in designed architectures. These structures
are incorporated into work for this dissertation on brain regeneration by creating
channels of 300 to 500 µm in diameter oriented both vertically and transversely, and
microgrooves of roughly 30-40 µm scale oriented in both directions.
The thoracic spinal cord contains both gray and white matter. In cross-section
the gray matter, located in the center, has a characteristic butterfly or H shape and
contains the cell bodies of mainly sensory neurons, motor neurons, and interneurons
(Figure 2.2). The ventral horn of the gray matter contains motor nuclei whose axons
project through the ventral roots to innervate skeletal muscles. The dorsal horn
contains sensory neurons which convey sensory information from dorsal root ganglion
sensory nuclei to the brain. Interneurons play a variety of roles in communication
between the brain and sensory and motor neurons or between motor neuron groups in
the spinal cord. Typically in a spinal cord injury the gray matter dies first, followed
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by the white matter (Schwab et al., 2006).
Surrounding the gray matter is the white matter which is divided generally into
dorsal, lateral, and ventral columns. The ascending and descending axonal pathways
are located in the white matter and can be subdivided into specific tracts connected
to specific parts of the brain and brain stem (Figure 2.2). When ascending or de-
scending axons reach appropriate segments of the spinal cord they branch inward to
the gray matter to connect with specific neurons. Propriospinal neurons are located
medially in the gray matter of the spinal cord and their axons can run up and down
the length of the spinal cord in the medial and ventral regions of the white matter,
called propriospinal tracts, to connect areas of the spinal cord for axial muscle con-
trol such as postural adjustment, or reach shorter distances to coordinate more distal
limb functions. Descending tracts from the brain stem are subdivided into two sys-
tems, the medial and lateral. Medial pathways from the brain stem, (vestibulospinal,
reticulospinal, and tectospinal tracts) connect with ventro-medially located interneu-
rons and propriospinal neurons in the grey matter, thus serving in the control of axial
and proximal muscles, like posture control and core muscles. These descending brain
stem tracts are found mainly in the lateral and ventro-medial columns of the white
matter. Lateral pathways from the brain stem descend mainly in the rubrospinal
tract from the midbrain and follow the dorso-lateral regions of the white matter.
This tract helps to control limb movements such as reaching and manipulating. An-
other source of descending axons in the spinal cord is the cerebral cortex, most
notably the motor cortex and are known as corticospinal fibers and tracts. Some
nerve fibers from the cortex, corticobulbar fibers, terminate at the brain stem and
indirectly continue through the descending tracts of the brain stem. There are also











Figure 2.2: A schematic diagram of the spinal cord. The cord is generally symmetric across the midline. Ascending
nerve fibers from the sensory neurons (green stars) project through the dorsal column (pink) of the white
matter. Descending fiber tracts from the motor cortex (dark blue) and brain stem (light blue) descend
in the lateral and ventral regions of the white matter to connect to the motor neurons (blue stars)
and interneurons (yellow stars). Propriospinal neurons are interneurons which can connect motor and
sensory neurons between different segments of the spinal cord by projecting through a ventro-medial
tract (yellow) of the white matter. This diagram highlights the circumferential location of fiber tracts
and the central location of neurons and transverse communications between those neurons.
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ventral and lateral white matter columns. The lateral corticospinal tract connects
largely to motor neurons in the lateral ventral horn and interneurons slightly medial
for control of limb movements. The ventral corticospinal tract controls more axial
muscles by connecting to more medial motor neurons on both sides of the spinal cord
in the ventral horn. Ascending axonal tracts are found largely in the dorsal column,
which carry the somatic sensory information to the brain stem. Ascending sensory
axons in the lateral and ventral columns carry pain and thermal sensations. (Kandel
et al., 2000)
The organization of the spinal cord can be simplified to circumferentially located
longitudinal fiber tracts surrounding and intermittently connected to a core of inter-
mingled cell bodies. The longitudinal tracts and central core delineations could be
replicated in designed architectures. The designs created for spinal cord regeneration
based on these architectural features are described in detail in Chapter 5.
CHAPTER III
PCL and PLGA degradable polymer sponges attenuate glial
scarring and lesion growth in traumatic brain injury
3.1 Overview
This study evaluated the response of rat cerebral cortex to two degradable poly-
mers, poly-(L-lactic-co-glycolic acid) (PLGA), and poly(e-caprolactone) (PCL), two
common materials in tissue engineering. PLGA has been extensively studied in the
brain for controlled drug release as injectable microspheres, and is generally accepted
as biocompatible in that capacity. Biocompatibility in other forms and for different
functions in the brain has not been widely studied. PCL was chosen as an alternative
to PLGA for its slower degradation and less acidic pH upon degradation. Porous
scaffolds were made from both polymers and implanted into rat cerebral cortex for 1
and 4 weeks. Morphology, defect size, activation of microglia (OX-42) and astrocytes
(GFAP), infiltration of activated macrophages (MHC-II), and ingrowth of neurons
(Tuj1) and progenitor cells (nestin) were analyzed by H&E staining and immunoflu-
orescence. PCL induced a lower inflammatory response than PLGA as demonstrated
by lower MHC-II and GFAP expression, and greater ingrowth. Both polymers alle-
viated astrocytic activation and prevented enlargement of the defect when compared
to an empty defect. Tuj-1, nestin, and GFAP positive cells were observed growing on
both polymers at peripheries of the sponge implants, demonstrating their permissive-
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ness to neural ingrowth. These findings suggest both polymers attenuate secondary
death and scarring, and that PCL might have advantages over PLGA.
3.2 Introduction
Brain lesions can result from a range of causes, from traumatic injury to disease.
The resultant voids are unable to retain or support injections of suspension treat-
ments such as cells or growth factors, which disperse quickly and lose effectiveness.
From a tissue engineering stand point, a delivery vehicle which fills the void and
contains drugs, neurotrophic factors, or cells has the potential to localize and main-
tain these treatments in the implant site, increasing the effectiveness, and provide
a path toward repair and reconstitution of the lost parenchyma which is lacking
in current clinical treatments (Thompson et al., 1999). This delivery vehicle must
satisfy certain design criteria, such as permissiveness to neural cell growth and im-
munological compatibility. Such scaffolds should not cause significant inflammatory
responses that may exacerbate the injury. Also mechanically the material must be
close enough to the tissue dynamics that surgical insertion and normal movements
of the patient do not cause more physical damage.
Treatment strategies for brain injuries such as hypoxic ischemia models focus
mainly on combination treatments using cells or neurotrophic factors (Park et al.,
2002; Tate et al., 2001; Tian et al., 2005a). Studies focusing on combination treat-
ments often overlook the potential importance of the material itself, and often com-
pare improvements and outcomes to a completely empty control site rather than the
untreated material. Different materials, such as gels and polymer fiber meshes, have
been studied separately. Unfortunately, there are no good comparisons of materials,
or any in-depth study of the relative biocompatibilities of the materials themselves.
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To provide an optimal outcome, it would be important to study and determine the
best combination of biologic therapy and material vehicles in a systematic approach.
PLGA and its related components are among the most widely investigated degrad-
able polymers in biomedical applications. The most extensive work with PLGA re-
garding material-brain research has been in controlled drug release applications in
the form of microspheres injected into brain (Fournier et al., 2003; Kou et al., 1997;
Popovic and Brundin, 2006). PLGA has been generally accepted as biocompatible
in that capacity. PCL has also been studied in the brain for controlled release micro-
spheres (Fournier et al., 2003; Menei et al., 1994), though not as extensively as PLGA.
PCL has been most commonly studied in other tissue types and has a history of drug
delivery and tissue engineering research elsewhere in the body (Sun et al., 2006;
Tang et al., 2004; Taylor et al., 1994). CNS inflammation has also been studied in
the context of electrode implants, where close contact of neuronal activity is desired
(Polikov et al., 2005). The current study investigated the biocompatibility of both
PLGA and PCL in the capacity of CNS tissue engineering. This approach requires
ingrowth and close contact with regenerating neuronal structures and integration of
host tissue within and around the implant. The structure of a scaffold in a defect,
rather than microspheres injected into tissue, may elicit a different host response.
The definition of biocompatibility here is slightly different from controlled release
and implantable electrodes, and we take guidance from both areas.
Acute inflammation in various brain injury models occurs over the course of
hours to days, encompassing hemorrhage, degeneration of damaged neurons, and
macrophage infiltration. By 7 days the inflammatory response has elicited secondary
cell death mechanisms which result in degeneration of white matter and expansion
of the original injury site. The ultimate size of the defect depends greatly on the
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initial insult. Thus different CNS defects may require different standards for success.
It may be useful in some cases with very large defects for the scaffold to have a much
longer residence time and sturdier support than can be offered by most hydrogels
and PLGA derivatives. PCL could fill this requirement. It is possible to use PCL as
a scaffold to carry cells within a hydrogel which infuses its pores, giving the implant
a definite structure and longer lasting support once the gel has dissipated and the
cells are establishing a full matrix. Though the degradation rates of both PLGA
and PCL can be adjusted through their initial molecular weights and the ratio of
lactic acid to glycolic acid in the case of PLGA, PCL may offer another benefit in
the lower acidity of its degradation product, caproid acid (pKa = 4.84) compared to
lactic acid (pKa = 3.08) and glycolic acid (pKa = 3.83).
Both polymers degrade by hydrolysis of the polymer chains. The difference in
their degradation rate is mostly a result of their differing hydrophobicities. PCL is
more hydrophobic than PLGA and therefore is hydrolyzed more slowly than PLGA.
As the molecular weight decreases, and polymer chains become smaller, macrophages
phagocytose these small particles. Porous implants of PCL and PLGA in a subcu-
taneous site were reported at 4 weeks to have lost 39% and 74% of their molecular
weights, respectively . Additionally, these researchers have shown PCL to have higher
total cellular ingrowth than PLGA after 4 weeks, and higher inflammatory cell in-
vasion and angiogenesis subcutaneously. This study compared PCL to PLGA in a
salt-leached sponge architecture as they relate to brain inflammation and ingrowth in
an injury site. We found that PCL elicited a lower immune response than PLGA and
both polymers lowered the scarring and secondary cell death after injury compared




PCL (CAPA 6501, MW 50 kDa, Solvay Chemicals, Houston, TX) and PLGA
(50:50, MW 54 kDa, Birmingham Polymers, Birmingham, AL) were used in this
study. Both polymers were made into sponges by solvent casting and porogen leach-
ing with 180-250 µm NaCl crystals in a Teflon mold to form 3mm diameter cylinders
of 3mm height. PCL was dissolved in acetone and PLGA in chloroform at 13%
(w:v) and dripped into salt packed molds from both ends until no more polymer
could be absorbed. Scaffolds were sterilized in 70% ethanol and then switched to
sterile Hanks Balanced Salt Solution and placed on a shaker one day prior to im-
plantation. Prior to scaffold fabrication PCL was cast separately with two different
solvents, acetone and chloroform to examine the microstructure and roughness under
scanning electron microscopy (SEM). Chloroform was used with PLGA because it
does not readily dissolve in acetone and it was necessary to maintain a comparable
surface to the PLGA microspheres previously studied and deemed biocompatible for
comparison with PCL.
Surgical implantation
Female Sprague-Dawley rats (250g) were anesthetized with isofluorane and heads
were mounted in a stereotaxic device. The skulls were exposed, bregma located, and
two positions marked, 3mm posterior and either 3.5 mm left or right. Holes were
drilled in the skull with a 3mm outer diameter trefine at one or both locations. Bone
chips were removed and then the same trefine, which had a marking 3mm from the
bottom of its burr, was used to drill 3mm into the cerebral cortex. The drill was kept
perpendicular to the surface of the skull and was held steady during the removal of
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brain tissue by the hole in the skull. PCL and PLGA sponges were inserted into the
right and left cavities, respectively. Controls received no implant in either cavity.
Other researchers report the lack of contralateral damage and inflammation in a
similar injury model (Chen et al., 2003). To confirm this in our own studies 7 rats
received only one defect in either the left or right hemisphere. The distribution is
described below. In the 1 week time point: 2 rats for control (no implant) both in the
right hemisphere, 1 rat with PLGA in the left hemisphere. In the 4 week time point:
3 rats with PCL with one left and two right hemisphere implants, and 1 rat with
PLGA in the left hemisphere. Tissue was examined histologically and with all the
immunofluorescent inflammation markers used in the study. Once it was confirmed
that the contralateral sides were not affected and there was no difference between the
right and left hemispheres, these data were combined with data for rats containing
2 defects per brain for a total of 4 samples per group per time point. At 1 week and
4 weeks, rats were perfused transcardially with 250 mL of 4% paraformaldehyde in
phosphate buffered saline. Brains were harvested and cryoprotected, then serially
sectioned coronally at 14 µm thickness in groups of 5 for further analysis. There was
no noticeable loss of motor function due to the surgeries and no noticeable difference
between groups in functional behavior after the surgery. All surgery, post-surgical
recovery and euthanasia were performed according to a protocol approved by the
University of Michigan Committee on the Use and Care of Animals.
Immunofluorescence, staining, and microscopy
Immunofluorescence was carried out using MHC-II (MCA46GA Serotec, Raleigh,
NC), nestin (Rat-401 Hybridoma Bank, University of Iowa), Tuj1 (MMS-435P Cov-
ance, Berkeley, CA), GFAP (G9269 Sigma), and CD11b(OX-42) (MCA275G Serotec)
primary antibodies were used with either Cy-2 conjugated secondary antibody or
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Streptavidin AlexaFluor-488 (Invitrogen/Molecular Probes, Carlsbad, CA) with Vec-
taStain ABC kit and biotinylated secondary antibodies (Vector Labs, Burlingame,
CA). Harris hematoxylin and alcoholic eosin stains were used for assessing a general
overview of inflammation and morphology. Images were taken using a Spot cam-
era and Spot Advanced software. All images for a montage were taken in the same
sitting with the same exposure and processing settings. When possible, all images
of sections with the same type of labeling were taken on the same day or two to
three consecutive days in batches of 15 to 20 slides. Positive and negative control
labeling was done with all primary and secondary antibodies using stock sections
from undamaged rat brain to verify their specificity and check background stain-
ing. A mixture of 5% donkey serum (Jackson ImmunoResearch Laboratories Inc.,
Westgrove,PA) and 3% BSA was used for blocking non-specific binding.
Quantification and statistics
Pixel areas for MHC-II and intensities for GFAP and OX-42 antibodies were
calculated using programs written in Matlab (Mathworks, Natick, MA) (program
details see section 6.3). The programs were written to allow the user to define
specific regions of interest and calculate mean grayscale values (between 0 and 255)
to determine background intensity and experimental group intensities. All intensity
data presented have background subtracted. Also, for MHC-II quantification images
were thresholded to exclude background areas. Then paths were drawn in Adobe
Photoshop to encompass total sponge area and used as a mask for the scaffold area to
be thresholded. Debris and halos were removed with Photoshop prior to calculating
areas based on intensity thresholds. GFAP and OX-42 intensities were calculated
from two neighboring 200 µm wide rectangles along each side of each scaffold (Figure
3.1).
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Figure 3.1: H&E stained sections of PCL and PLGA polymer constructs in brain cavities. (C) regions L1 and L2
are illustrated on this section. All images (except for insets) were taken at 2x magnification and tiled
together. Scale bars are 2 mm unless otherwise labelled. Control at (A) 1 week and (B) 4 weeks, PCL
at (C) 1 week and (D) 4 weeks, and PLGA at (E) 1week and (F) 4 weeks. (inset B and inset E) Gross
images before sectioning illustrate the visual difference between (B) control and (E) a defect containing
material. (inset D) 10x mag of H&E section showing parenchyma at the bottom corner of a defect site
on the right-hand side with PCL polymer (arrows) and blood vessels (arrow heads).
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Region L1 was the region immediately adjacent to the defect and L2 was the
region just adjacent to L1. Each sample section had two L1 regions and two L2 re-
gions, which were combined for an average. Lengths varied and regions were chosen
to exclude edge effect fluorescence, the hippocampus, dirt particles, air bubbles, and
folds. Three regions on each section were chosen from areas of the cortex unaffected
by the surgeries to calculate background intensities on each slide. The average total
area used to calculate background was 0.09 mm2. Statistical significance was cal-
culated using a 2-way ANOVA over time and material for MHC-II areas and defect
widths and 3-way ANOVA for GFAP and OX-42 intensities over time, material, and
region. P levels below 0.05 were considered statistically significant. Tukeys Least
Significant Difference was used in post-hoc tests when ANOVA showed significance
among groups. Error bars in graphs show standard deviation. Cellular areas within
sponges were calculated from H&E stained sections since the polymers did not stain,
while combined cellular and material areas were calculated from immunofluorescence
images due to the polymers persistence on slides after aqueous processing and their
low-level autofluorescence. Defect sizes were measured with the measuring tool in
Adobe Photoshop. Serial sections were measured until the middle of the defect was
found and that measurement was used. Distances were measured across the top and
across the middle as parallel lines, perpendicular to the apparent angle of entry for
the axis of the cylinder sponges.
3.4 Results
Polymer Morphology
Acetone was chosen as the solvent for PCL because of its relative ease and safety
compared to chloroform. However, use of the two solvents results in two different
surface roughnesses as seen under SEM (Figure 3.2). Use of acetone results in a
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rougher surface with additional porosity compared to the relatively smooth surface
which results from using chloroform. The surface directly contacting salt revealed
that in addition to the salt-generated pores, smaller pores between the walls were
present when using acetone as solvent. The increased surface roughness and porosity
were additional motivating factors for using acetone as the solvent to potentially
increase cell attachment and nutrient diffusion through the scaffolds.
Figure 3.2: SEM micrographs of PCL surfaces cast with acetone and chloroform as solvents. The PCL surface
which was in contact with a salt crystal has more pores when cast in (a) acetone than (b) chloroform.
Scale bars in a,b 50 µm. The roughness of the surface on closer inspection is greater using (c) acetone
that (d) chloroform. Scale bars c,d 20 µm.
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Gross morphology
Defects in control brains without any polymer implant increased in size over the
course of the experiment, whereas both PCL and PLGA helped to maintain the
defect close to its original size. Brain tissue encompassed the sponges rather than
shrinking away form it (Figure 3.1e inset). By measuring serial sections to find the
middle of each scaffold, the defect widths revealed no significant difference between
the two different polymers, but were significantly different from the controls. Both
polymers were able to maintain the defect sizes at approximately the original size,
while the control defect expanded to over 4 mm in diameter (Figure 3.1b inset and
Figure 3.3a). From 2-way ANOVA over group and time only the interaction had
significance, P = 0.0194. From the post-hoc analysis there was no difference between
the two polymers at both time points. Only the control group was significantly
larger than the materials at 4 weeks. At 4 weeks a noticeable difference in color
and morphology appeared between PCL and PLGA sponges (Figure 3.1). After
perfusion, PCL sponges were the same color as the surrounding brain tissue and
PLGA sponges had a brownish red color that was consistent in all replicates. This
may be a reflection of vascular connectivity within the sponges allowing blood to be
perfused more thoroughly in PCL than PLGA sponges.
Coronal sections through the brains were used to observe the polymer sponge
structure in the brain defect (Figure 3.1). Shapes reminiscent of salt crystals were
evident. Groups at 1 week looked less empty, as fibrin clots remained. By 4 weeks
clots cleared, but some peripheral tissue integration remained. Cells were seen in
close contact with polymers and some vascularization was seen (Figure 3.1d inset).
Additionally, at 4 weeks sponges began to degrade and had overall smaller volumes.
In the H&E images, polymers were dissolved by the xylenes during staining, leaving
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Figure 3.3: Quantitative data comparing control, PCL, and PLGA from image analysis. (A) Defect widths for
each group at 1 and 4 weeks. Starred control is significantly larger than all other groups and times
(P ¡ 0.05). (B) Ox-42 intensities after background subtraction. Starred groups were not different from
each other, but significantly higher than the unstarred groups. Unstarred groups were not significantly
different from each other. (C) GFAP intensities after background subtraction. All starred groups are
higher than unstarred groups. The two doubly starred groups are significantly different from each
other. Unstarred groups are not significantly different from each other. (see text for detailed P values)
